Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis.
Although amphotericin B desoxycholate is considered the most effective treatment for disseminated Paracoccidioides brasiliensis infections, little is known about the efficacy of lipid-based formulations of amphotericin B in this infection. In this study, we treated four adults with the juvenile form of paracoccidioidomycosis with 3 mg/kg/day of amphotericin B colloidal dispersion for at least 28 days. Although all of the patients initially responded by clinical observation, all four patients relapsed within six months. The use of amphotericin B colloidal dispersion for the initial induction of paracoccidioidomycosis failed to cure this infection. Possible reasons for failure include dose, duration, or reduced efficacy of this lipid preparation. For many fungal infections, lipid-based preparations have been shown to have a therapeutic-toxic advantage, but our experience with Paracoccidioides infections suggests that more careful studies will need to be performed before they can be recommended for use in this mycosis.
Dietze
R
R
Departamento de Medicina Social, Centro Biomedico, Universidade Federal do Espirito Santo, Vitoria, Brazil.
Fowler
V G
VG
Steiner
T S
TS
Pecanha
P M
PM
Corey
G R
GR
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003102:Colloids; D006801:Humans; D010228:Paracoccidioides / Q000302:isolation & purification*; D010229:Paracoccidioidomycosis / Q000188:drug therapy* / Q000382:microbiology; D017211:Treatment Failure
D000935:Antifungal Agents; D003102:Colloids; D000666:Amphotericin B